Abbott Laboratories $25 billion acquisition of St Jude Medical

28/4/2016

Public acquisition

Value:

$ 25 billion

Status:

Completed

Date:

28/4/2016

Overview:

Abbott Laboratories has acquired St Jude Medical for $25 billion.
Both are manufacturers of medical devices.
Wachtell Lipton Rosen & Katz advised acquirer Abbott Laboratories.
Gibson Dunn & Crutcher advised St Jude Medical.

Kurt Stumpo - Journalist - North America and the Caribbean

Jurisdiction:

United States

Deal type:

Public acquisition

Practice area:

M&A

Industry sectors:

Healthcare
Industrials and manufacturing

Firms:

Gibson Dunn & Crutcher

Party: St Jude Medical (Target)

Wachtell Lipton Rosen & Katz

Party: Abbott Laboratories (Acquirer)

Related deals